Last Updated: August 8, 2026

Apotex Corp Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for APOTEX CORP

APOTEX CORP has thirteen approved drugs.

There are two tentative approvals on APOTEX CORP drugs.

Summary for Apotex Corp

US Patents:	0
Tradenames:	11
Ingredients:	11
NDAs:	13
Patent Litigation for Apotex Corp:	See patent lawsuits for Apotex Corp
PTAB Cases with Apotex Corp as petitioner:	See PTAB cases with Apotex Corp as petitioner

Drugs and US Patents for Apotex Corp

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Corp	RILUZOLE	riluzole	TABLET;ORAL	091300-001	Jun 18, 2013		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Apotex Corp	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	200878-003	Apr 20, 2012		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Apotex Corp	AZITHROMYCIN	azithromycin	TABLET;ORAL	065508-001	Jul 13, 2011		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Apotex Corp	AZITHROMYCIN	azithromycin	TABLET;ORAL	065509-001	Jul 13, 2011		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Apotex Corp	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090790-002	Oct 6, 2010		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Apotex Corp	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090790-003	Oct 6, 2010		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.